Johan Gileus

Johan Gileus serves as the Chief Financial Officer at Alligator Bioscience AB since August 2024, while also being a Partner at PÄAB since May 2016 and the CEO of Gileus Consulting AB since June 2015. Prior to these roles, Johan Gileus held the positions of Deputy CEO/CFO and Acting CEO at InDex Pharmaceuticals Holding AB from May 2017 to June 2024, overseeing business development, intellectual property, and quality assurance. Johan Gileus has also contributed as a Board Member for Bygghemma Group and Haldex, where Johan chaired the audit committee. Previously, Johan Gileus was a Partner at Deloitte in the Financial Advisory practice from May 2002 to June 2015. Educational background includes studies at Stockholm University from 1987 to 1991.